Alexandria Real Estate Equities
ARE
#2281
Rank
S$10.64 B
Marketcap
S$61.87
Share price
-0.39%
Change (1 day)
-43.19%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2026 (TTM): -S$0.76 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are S$2.76 Billion. In 2025 the company made an earning of -S$1.27 Billion a decrease over its 2024 earnings that were of S$0.88 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.76 Billion-40.6%
2025 -S$1.27 Billion-242.13%
2024 S$0.88 B96.11%
2023 S$0.45 B-53.56%
2022 S$0.97 B-3.96%
2021 S$1.01 B-20.26%
2020 S$1.27 B72.88%
2019 S$0.73 B3.11%
2018 S$0.71 B73.54%
2017 S$0.41 B464.88%
2016 S$72.95 M-77.32%
2015 S$0.32 B36.31%
2014 S$0.23 B-10.81%
2013 S$0.26 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$8.81 B-1,282.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$42.88 B-5,849.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$13.13 B-1,860.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-S$2.5 Billion 234.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$1.48 B-298.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$15.20 B-2,138.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$1.43 B-292.46%๐Ÿ‡บ๐Ÿ‡ธ USA